These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 17550303)
1. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303 [TBL] [Abstract][Full Text] [Related]
2. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG; Kim TD; Li G; Yoon WH; Chae CB Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619 [TBL] [Abstract][Full Text] [Related]
5. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Hiratsuka S; Nakao K; Nakamura K; Katsuki M; Maru Y; Shibuya M Mol Cell Biol; 2005 Jan; 25(1):346-54. PubMed ID: 15601855 [TBL] [Abstract][Full Text] [Related]
6. Expression and localization of vascular endothelial growth factor A (VEGFA) and its two receptors (VEGFR1/FLT1 and VEGFR2/FLK1/KDR) in the canine corpus luteum and utero-placental compartments during pregnancy and at normal and induced parturition. Gram A; Hoffmann B; Boos A; Kowalewski MP Gen Comp Endocrinol; 2015 Nov; 223():54-65. PubMed ID: 26414127 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]
8. Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer. Syed Khaja AS; Dizeyi N; Kopparapu PK; Anagnostaki L; Härkönen P; Persson JL PLoS One; 2013; 8(8):e72210. PubMed ID: 23991063 [TBL] [Abstract][Full Text] [Related]
9. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Weigand M; Hantel P; Kreienberg R; Waltenberger J Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160 [TBL] [Abstract][Full Text] [Related]
10. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089 [TBL] [Abstract][Full Text] [Related]
11. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Guan F; Villegas G; Teichman J; Mundel P; Tufro A Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608 [TBL] [Abstract][Full Text] [Related]
12. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop. Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481 [TBL] [Abstract][Full Text] [Related]
13. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach. Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451 [TBL] [Abstract][Full Text] [Related]
14. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490 [TBL] [Abstract][Full Text] [Related]
15. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer. Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886 [TBL] [Abstract][Full Text] [Related]
16. Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer. Farzaneh Behelgardi M; Zahri S; Gholami Shahvir Z; Mashayekhi F; Mirzanejad L; Asghari SM Mol Biol Rep; 2020 Mar; 47(3):2061-2071. PubMed ID: 32072404 [TBL] [Abstract][Full Text] [Related]
17. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells]. Zhang X; Xu WH; Ge YL; Hou L; Li Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523 [TBL] [Abstract][Full Text] [Related]
19. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818 [TBL] [Abstract][Full Text] [Related]
20. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR]. Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]